The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/6795499

Download in:

View as

General Info

PMID
6795499